CLONIDINE and DYSPNOEA

Overview

DYSPNOEA is the #8 most commonly reported adverse reaction for CLONIDINE, manufactured by Actavis Pharma, Inc.. There are 2,295 FDA adverse event reports linking CLONIDINE to DYSPNOEA. This represents approximately 2.1% of all 108,277 adverse event reports for this drug.

Patients taking CLONIDINE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for CLONIDINE, but still significant enough to appear in the safety profile.

Other Side Effects of CLONIDINE

In addition to dyspnoea, the following adverse reactions have been reported for CLONIDINE:

• DRUG INEFFECTIVE — 3,867 reports
• PAIN — 3,037 reports
• FATIGUE — 2,925 reports
• NAUSEA — 2,918 reports
• OFF LABEL USE — 2,852 reports
• HEADACHE — 2,798 reports
• HYPERTENSION — 2,599 reports
• DIARRHOEA — 2,202 reports
• CHRONIC KIDNEY DISEASE — 2,113 reports
• VOMITING — 2,032 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does CLONIDINE cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 2,295 FDA reports for CLONIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with CLONIDINE?

DYSPNOEA accounts for approximately 2.1% of all adverse event reports for CLONIDINE, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking CLONIDINE?

If you experience dyspnoea while taking CLONIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages